Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 2:36 AM
Ignite Modification Date: 2025-12-26 @ 1:14 AM
NCT ID: NCT02784834
Description: None
Frequency Threshold: 0
Time Frame: 4 months
Study: NCT02784834
Study Brief: Dimethylfumarate (DMF) in Relapsed/Refractory CLL/SLL
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Dimethyl Fumarate (DMF) Cohort 1: dimethyl fumarate 120 mg PO BID (approximately 12 hours apart) for 2 x 28 day cycles. 0 None 0 2 2 2 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Allergic Reaction NON_SYSTEMATIC_ASSESSMENT Immune system disorders None View
Lymph node pain NON_SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders None View
Flushing NON_SYSTEMATIC_ASSESSMENT Vascular disorders None View
Fatigue NON_SYSTEMATIC_ASSESSMENT General disorders None View
Thrombocytopenia NON_SYSTEMATIC_ASSESSMENT Investigations None View